United States Single Cell Genomics and Proteomics Growth Opportunities: The Integration of Multi-Omics Data to Drive the Development of Personalized Medicine
16 Jan 2024
DUBLIN, Jan. 16, 2024 /PRNewswire/ -- The "Growth Opportunities in Single Cell Genomics and Proteomics in the United States" report has been added to
ResearchAndMarkets.com's offering.
In recent years, single-cell analysis has changed rapidly. It began as a niche, specialized technology with few companies offering solutions, which then became commonly used in academia. Subsequently, its use has spread to areas such as biopharma, with more companies investing in the research and development (R&D) of single-cell analysis projects.
Globally, the single-cell genomics and proteomics market is growing at high rates. The United States represents about 60% of the total market and is on track to increase about 12% to 16% annually. Much of that growth is characterized by public funding, such as funding by the National Institutes of Health (NIH) and increasing biopharma investments.
Greater adoption and better handling of artificial intelligence (AI) and machine learning (ML) tools will drive this market's growth. These novel tools encourage the development of software and data analysis solutions to help researchers interpret data.
This report examines the US single-cell genomics and proteomics market and provides a forecast from 2023 to 2028. It assesses the market for single-cell analysis tools used for analytical and isolation purposes across workflows, technologies, and applications.
The research provides information on market concentration and evolution, leading providers, application areas, and technologies. This study will help vendors understand critical trends emerging for various application domains.
Key Topics Covered:
Growth Opportunity Analysis
Scope of Analysis
Segmentation
Key Competitors by Workflow
Growth Metrics
Growth Drivers
Growth Restraints
Forecast Assumptions
Revenue Forecast
Revenue Forecast Analysis
Revenue Forecast by Workflow
Percent Revenue Forecast by Workflow
Forecast Analysis by Workflow
Revenue Forecast by Application
Percent Revenue Forecast by Application
Forecast Analysis by Application
Revenue Forecast by Technology
Percent Revenue Forecast by Technology
Forecast Analysis by Technology
Pricing Trends and Forecast Analysis
Competitive Environment
Revenue Share
Revenue Share Analysis
Key Companies to Watch
Key Technologies and Workflow - Competitor Landscape
Interest in Single-cell Genomics
Single-cell Analysis Workflow Technology
Key Partnerships and Collaborations
Funding Trends
Early-stage Company Funding Trends for Single-cell Analysis
Research Center Funding Trends for Single-cell Analysis
Single-cell Genomics and Proteomics Cores around the World
Growth Opportunity Universe
Growth Opportunity 1: Bioinformatics Tools and Platforms for Analyzing and Interpreting Large-scale Single-cell Data
Growth Opportunity 2: Automation and High-throughput Solutions for Tissue Dissociation Processes
Growth Opportunity 3: The Integration of Multi-Omics Data to Drive the Development of Personalized Medicine
For more information about this report visit https://www.researchandmarkets.com/r/oorsz2
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.